BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 23899994)

  • 1. Pam3CSK(4) enhanced beta cell loss and diabetogenesis: the roles of IFN-gamma and IL-17.
    Al Shamsi M; Shahin A; Iwakura Y; Lukic ML; Mensah-Brown EP
    Clin Immunol; 2013 Oct; 149(1):86-96. PubMed ID: 23899994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
    Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
    Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of autoimmune diabetes by TLR2 tolerance.
    Kim DH; Lee JC; Kim S; Oh SH; Lee MK; Kim KW; Lee MS
    J Immunol; 2011 Nov; 187(10):5211-20. PubMed ID: 21998452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
    Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
    Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
    Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
    J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of carbonyl iron against multiple low-dose streptozotocin-induced diabetes in rodents.
    Vujicic M; Saksida T; Mostarica Stojkovic M; Djedovic N; Stojanovic I; Stosic-Grujicic S
    J Cell Physiol; 2018 Jun; 233(6):4990-5001. PubMed ID: 29215791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.
    Nizri E; Irony-Tur-Sinai M; Lory O; Orr-Urtreger A; Lavi E; Brenner T
    J Immunol; 2009 Nov; 183(10):6681-8. PubMed ID: 19846875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell receptor activation of human CD4(+) T cells shifts the innate TLR response from CXCL8(hi) IFN-γ(null) to CXCL8(lo) IFN-γ(hi).
    Akhade AS; Qadri A
    Eur J Immunol; 2015 Sep; 45(9):2628-37. PubMed ID: 26205220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.
    Herold KC; Vezys V; Sun Q; Viktora D; Seung E; Reiner S; Brown DR
    J Immunol; 1996 May; 156(9):3521-7. PubMed ID: 8617981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
    Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS
    Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.
    Ali R; Naqvi RA; Kumar S; Bhat AA; Rao DN
    Scand J Immunol; 2013 May; 77(5):361-71. PubMed ID: 23480362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of resistant and susceptible genotype, IL-1, and lymphoid organ on Trichinella spiralis-induced cytokine secretion.
    Pond L; Wassom DL; Hayes CE
    J Immunol; 1992 Aug; 149(3):957-65. PubMed ID: 1353100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.
    Nardelli DT; Burchill MA; England DM; Torrealba J; Callister SM; Schell RF
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1075-84. PubMed ID: 15539509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TLR2 agonists lipoteichoic acid and Pam3CSK4 induce greater pro-inflammatory responses than inactivated Mycobacterium butyricum.
    Gambhir V; Yildiz C; Mulder R; Siddiqui S; Guzzo C; Szewczuk M; Gee K; Basta S
    Cell Immunol; 2012 Nov; 280(1):101-7. PubMed ID: 23298864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice.
    Tan AC; Mifsud EJ; Zeng W; Edenborough K; McVernon J; Brown LE; Jackson DC
    Mol Pharm; 2012 Sep; 9(9):2710-8. PubMed ID: 22823162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin.
    Mensah-Brown EP; Shahin A; Al-Shamisi M; Wei X; Lukic ML
    Eur J Immunol; 2006 Jan; 36(1):216-23. PubMed ID: 16358360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin.
    Zdravkovic N; Shahin A; Arsenijevic N; Lukic ML; Mensah-Brown EP
    Mol Immunol; 2009 Nov; 47(1):28-36. PubMed ID: 19356801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.